Regulatory T cells (T regs ) play a fundamental role in regulating the immune system in health and disease. Considerable evidence exists demonstrating that transfer of T regs can cure colitis and a variety of other inflammatory disorders. However, little is known about the effects of inflammation on resident T regs . Mice (BALB/c or C57BL/6) treated with an intrarectal instillation of the haptenizing agent 2,4-dinitrobenzene sulfonic acid (DNBS) develop an acute inflammatory disease, the histopathology of which peaks at 3 days posttreatment and resolves spontaneously thereafter. T he immune system is tasked with protecting the host from infection and disease and so must discriminate between self or otherwise harmless Ags and noxious, potentially dangerous Ags. In the intestine this represents a formidable challenge, because the large surface area required for nutrient digestion and absorption also provides ample opportunity for pathogen entry. Moreover, the mammalian intestine, particularly the lumen of the colon, is home to a vast microbiota that in this location is not only considered commensal but of benefit to the host (1-3). However, if the same organisms gain entry to the blood the outcome can be sepsis, multiorgan failure, and death. In light of this, it is not surprising that the gastrointestinal tract is the largest reservoir of T cells in the body and is often described as being in a continuous state of controlled inflammation, a state achieved through an exquisitely balanced interplay between proinflammatory, antiinflammatory, and immunosuppressive/regulatory mechanisms.
T he immune system is tasked with protecting the host from infection and disease and so must discriminate between self or otherwise harmless Ags and noxious, potentially dangerous Ags. In the intestine this represents a formidable challenge, because the large surface area required for nutrient digestion and absorption also provides ample opportunity for pathogen entry. Moreover, the mammalian intestine, particularly the lumen of the colon, is home to a vast microbiota that in this location is not only considered commensal but of benefit to the host (1-3). However, if the same organisms gain entry to the blood the outcome can be sepsis, multiorgan failure, and death. In light of this, it is not surprising that the gastrointestinal tract is the largest reservoir of T cells in the body and is often described as being in a continuous state of controlled inflammation, a state achieved through an exquisitely balanced interplay between proinflammatory, antiinflammatory, and immunosuppressive/regulatory mechanisms.
Understanding the complexity of immune homeostasis and how this determines whether one recovers or succumbs to disease is of paramount importance, and a number of key soluble (e.g., TGF-␤ and IL-10) and cellular (e.g., regulatory T cells (T regs ) 3 ) regulatory agents have been identified. Natural T regs develop in the thymus where their transcriptional programming is imprinted and controlled by the transcription factor Foxp3 (4 -6) . In addition to natural T regs and although the issue is a contentious one, there are data to support the possibility that peripheral T cells can be induced into a regulatory phenotype when stimulated appropriately to elicit Foxp3 expression (7) . The site of T reg -controlled suppression is also a subject of debate; convincing data demonstrate that T reg suppression of mucosal inflammation is achieved during the priming of effector T cells in secondary lymphoid tissue (8) , and there is also substantive data showing that immunosuppression at the effector site is necessary (9) .
The importance of T regs cells in the gastrointestinal tract has been demonstrated in rodent models of colitis, where spontaneous disease develops in their absence or upon the transfer of effector T cells devoid of T regs into immunodeficient animals (10) . Although there is little doubt that T regs can suppress the development of inflammatory disease, there is a paucity of data on the reciprocal interaction, i.e., the effect(s) that inflammation has on T regs resident in the colon. Thus, we asked the following three questions. First, does colitis alter the colonic Foxp3 ϩ T cell population? Second, if distinct changes in the resident T reg population occur, are these events paralleled in secondary lymphoid tissues? Third, what is the mechanism underlying inflammation-induced changes in local, that is, colonic T regs ? Using established models of murine colitis, the data herein show for the first time that colitis results in a transient loss of Foxp3 ϩ T cells that is restricted to the colon with no involvement of the small bowel, mesenteric lymph nodes, or spleen. Mechanistic investigations indicate that the depletion of Foxp3 ϩ T cells in the colon is a consequence of Fas-Fas ligand (FasL)-induced death of this regulatory T cell population.
Materials and Methods

Animals and the induction of colitis
Six-to eight week old male BALB/c, C57BL/6, B6.Cg-Igh a Thy1 a Gpi1 a /J (referred to as Thy1.1), and B6.MRL-Fas lpr /J (referred to as B6-Fas Ϫ/Ϫ ) mice were purchased from The Jackson Laboratory. BALB/c lpr/lpr gld/ gld mice were provided by Dr. J. Erikson (Wistar Institute, Philadelphia PA). All mice were maintained in specific pathogen-free conditions at the University of Calgary (Calgary, Alberta, Canada) for 1 wk before use. Colitis was evoked by intrarectal (i.r.) instillation of 3 or 5 mg of 2,4-dinitrobenzene sulfonic acid (DNBS) in 100 l of a 1:1 ethanol (EtOH): PBS solution via a 3-cm catheter in BALB/c and C57BL/6 mice, respectively. Mice receiving 50% EtOH alone or PBS only served as timematched controls. Mice were sacrificed at 3, 8, 14, or 21 days posttreatment (EtOH controls or DNBS). In other studies, mice were treated with, oxazolone (5 mg i.r. in 50% EtOH), and assessed 8 days later. Colitis was assessed by clinical disease score (maximum ϭ 5) based on presence (1) or absence (0) of the following: Ͼ10% weight loss, wet anus/soft stool/empty colon, shortening of the colon, anal bleeding/occult blood, macroscopic ulcers, and death. Histological damage scores were determined on H&E-stained sections (formalin-fixed, paraffin-embedded tissues; 3-m sections) and are based on the following: loss of architecture, 0 -3; inflammatory infiltrate, 0 -3; goblet-cell depletion, 0 or 1; ulceration, 0 or 1; edema, 0 or 1; muscle thickening, 0 -2; and presence of crypt abscesses, 0 or 1 (maximum score ϭ 12) as published previously (11) . All procedures were approved by the animal care committee at the University of Calgary and conformed to Canadian guidelines on animal care.
RT-PCR
A 1-cm segment of a full thickness colon was excised from the mid-colon, snap frozen in liquid N 2 , processed using TRIzol according to manufacturer's instructions (Invitrogen), and used for semiquantitative RT-PCR. Isolated RNA was reverse transcribed using an Iscript kit (Bio-Rad) and 1 g of RNA was added along with the reverse transcriptase enzyme to the premixed buffer (dNTP, oligo(dT) primers, RNase H inhibitor). Synthesis of cDNA was performed in a Bio-Rad MyCycler, and 1 g of this template cDNA was used in PCR with gene-specific primers (Table I ) and the following parameters: initial denaturing (94°C for 5 min), 35 cycles (denaturing at 94°C for 30 s, annealing at 58°C for 5 s, extension at 72°C for 10 s), and a final extension at 72 o C for 5 min. The PCR products were electrophoresed through 2% agarose gels containing 0.5 mg/ml ethidium bromide and visualized under UV light.
Cell isolations
Splenocyte and mesenteric lymph node (MLN) cell isolation. Spleens or MLNs were removed and placed into separate sterile tubes containing RPMI 10 medium supplemented with 5% FBS and 2% (v/v) penicillin/ streptomycin (all from Sigma-Aldrich) and then mechanically disrupted by pressing through a 100-m cell strainer. Pelleted cells were resuspended in 2 ml of ACK lysis buffer (0.15M NH 4 Cl, 10 mM KHCO 3 , and 0.1 MM EDTA; all from Sigma-Aldrich) for 2 min to remove erythrocytes. Following centrifugation, cells were resuspended at 5 ϫ 10 6 /ml for immediate use or purified into an enriched CD4
ϩ T cell population (see below).
Colonic lamina propria lymphocyte (LPL) isolation. LPLs were isolated according to a standard protocol (12) with minor modifications. Briefly, after mesentery and fat were removed, the excised colons were opened and cut into 0.5-mm pieces. Tissues were washed six times in Ca 2ϩ -and Mg 2ϩ -free (CMF) HBSS (Invitrogen). Tissues were incubated in tissue culture flasks on end with sterile stir bars in CMF HBSS with EDTA (8 mM) stirred at 300 rpm on stir plates at room temperature. After 15 min the supernatant containing epithelial cells and intraepithelial lymphocytes was discarded, fresh CMF HBSS with EDTA was added and the process was repeated an additional three times. Release of LPLs was accomplished by collagenase (150U/ml final, fraction V; Sigma-Aldrich) digestion of tissue, with agitation by stirring for 1 h at 37°C followed by the recovery of cells from the supernatant. To increase viability of the cells, 20 ml of RPMI 10 was added to the supernatants to dilute and neutralize the collagenase. Digestion with collagenase was repeated twice more, and the recovered cells were pooled, washed twice in CMF HBSS, resuspended at 10 6 /ml, and kept on ice before use.
CD4
؉ T cell and T reg purification. CD4 ϩ T cells were purified from naive BALB/c spleens using MACS according to the manufacturer's instructions (Miltenyi Biotec). Briefly, cells were resuspended in sterile, degassed 5% BSA/PBS (w/v) and incubated with a mixture of biotinylated Abs, leaving CD4 ϩ T cells untouched, for 10 min at 4°C. Following the addition and binding of magnetic biotinylated microbeads, cells were added to a separation column held in a magnetic field that captured and retained the labeled cells while unlabeled CD4
ϩ T cells are collected as flow through. Flow cytometry confirmed Ն95% CD4 ϩ purity (data not shown). T reg cells were purified in a similar manner, with the additional 
Adoptive cell transfer
Purified T regs were adoptively transferred to naive synergic recipients by i.p. injection of 10 7 cells in 100 l of PBS (13, 14) . Preliminary experiments were conducted with the transfer of CFSE-labeled BALB/c, or Thy1.2 ϩ (C57BL/6) T regs into synergic BALB/c or Thy1.1 ϩ (C57BL/6) hosts to determine whether i.p. injection would allow for the homing and subsequent recovery of lamina propria T regs 11 days after transfer. In other experiments, EtOH or 5 mg of DNBS (i.r.) was administered to recipient mice 3 days post-T reg transfer, and T reg recovery from the colon was assessed 8 days post-DNBS treatment. 
In vitro induction of Foxp3 ϩ T regs
Following a published protocol (14), 10 6 mixed splenocytes, MLN cells, or purified CD4
ϩ T cells were cultured in the presence of plate-bound anti-CD3 Abs (1 g/ml) with or without 2 g/ml soluble anti-CD28 Abs (BD Biosciences) and 5 ng/ml TGF-␤ (R&D Systems). Five days later, Foxp3 protein expression was determined by immunoblotting. In addition, identical cell cultures also received mouse recombinant IFN-␥, IL-4, or TNF-␣ (all 20 ng/ml; Peprotech) simultaneously with TGF-␤ treatment or were 
Western blotting
Protein was extracted from isolated immune cells, full thickness colon, or mucosal scrapings. Laemmli sample buffer was added to 20 g of protein and the preparation was boiled for 5 min and then subjected to discontinuous SDS-PAGE (4% stacking pH 6.8, 10% separating pH 8.8). Resolved proteins were transferred onto polyvinylidene difluoride membranes and blocked for 1 h in TBST (5% milk, Tris-buffered saline, and Tween 20). Membranes were washed three times (5 min each) and incubated for either 1 h (room temperature) or overnight (4°C) with primary Abs against one of the following Ags: Foxp3 (eBioscience), Zap70 mAb, cleaved caspase 3, total caspase 3, phospho-SMAD2, phospho-STAT1 Y701 (Cell Signaling Technology), and SMAD7 (Abcam), STAT1 (Santa Cruz Biotechnology) (all of the Abs were used at 1/1000 and were rabbit anti-mouse, except for Foxp3, which was rat anti-mouse). Following washing, membranes were incubated with the appropriate secondary Ab (1/5000) in 5% TBST for 1 h at room temperature, washed extensively, and developed using ECL solution (15) .
Flow cytometry
Flow cytometry was performed on freshly isolated splenocytes, MLN cells, and LPLs. In addition, blood obtained from cardiac puncture was collected into heparin sulfate-containing tubes and mixed, and 200 l was transferred to a 50-ml conical tube along with 20 ml of PBS. After erythrocyte lysis (see above) the immune cells were resuspended, stained, and subjected to FACS. Cell staining was performed with anti-CD4, anti-Fas, anticleaved caspase 3 (BD Biosciences), anti-CD25, -anti-␣ 4 ␤ 7 (LPAM-1), anti-CD90.2 (Thy1.2), anti-FasL, and anti-Foxp3 (BioLegend) Abs. Briefly, 10 6 cells were transferred to flow cytometry tubes and washed once with staining buffer (BioLegend). Cells were resuspended in 100 l of staining buffer and surface staining was performed for 20 min in the dark. Cells were washed twice in staining buffer followed by fixation and permeabilization in freshly prepared 1ϫ Fix/Perm buffer (BioLegend). After extensive washing to remove residual fixative, cells were resuspended in permeabilization buffer and incubated with anti-mouse Foxp3-Alexa Fluor488. Following washing of the cells, data were acquired and analyzed on a FACScan using CellQuest Pro (BD Biosciences). Analysis was conducted on lymphocytes based on forward scatter and side scatter, with unstained, single stained, and isotype controls used to determine compensation and setting of gates. Absolute numbers of cells were calculated as described previously (16) : absolute number ϭ (percentage CD4 ϩ Foxp3 ϩ among total cells) ϫ (total cell count)/100. Intracellular staining for SMAD7 and phosphorylated SMAD2 was performed as indicated above with Abs labeled with anti-rabbit Fab conjugated to either Alexa Fluor488 or PE (Zenon kit; Invitrogen).
Immunohistochemistry
Excised tissues (mid-colon, spleen, and MLN) were formalin fixed and paraffin embedded and 5-m sections were collected onto coded slides. After deparaffinization, re-hydration, and epitope recovery (30 min in citrate buffer (citric acid and Triton X-100) in a food-steamer), endogenous peroxidases were blocked by incubation in 3% H 2 O 2 (5 min). Sections were washed in TBS, blocked for 1 h with an IgG blocking reagent (mouseon-mouse (MoM) kit, Vector Laboratories), washed in TBS (3 ϫ 5 min), incubated at room temperature in MoM diluent for 5 min, and then treated with anti-Foxp3 (1/100; BioLegend) Ab for 30 min. Following three TBS washes, sections were incubated in biotinylated secondary Ab as indicated by the manufacturer's instructions (Vector Laboratories) for 10 min. The biotin-streptavidin-based color development was performed using the Vectorstain Elite ABC kit with diaminobenzidine as a substrate that gives a positive brown reaction product. Slides were counterstained in hematoxylin, dehydrated and Foxp3 ϩ cells enumerated in five random high power fields (ϫ400 original magnification per tissue section). Staining for Fas ligand was performed on sections as described above with the following exceptions. Heat-induced epitope recovery was performed for 20 min followed by rapid cooling by placing the vessel containing the slides and buffer in ice-cold water for 10 min. Blocking was performed by incubation in 0.3% H 2 O 2 for 30 min. Polyclonal Ab directed against FasL was added at 1/100 (Abcam) and incubated overnight at 4°C. Negative controls in which primary Ab was omitted and positive control tissues (i.e., spleen) were used to ensure specific staining. 
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Data presentation and analysis
The gels or other images shown are always representative of at least three separate experiments. Graphical data are mean Ϯ SE and n values refer to the number of mice used in two or more separate experiments. Statistical analysis was performed for multiple groups using one-way ANOVA followed by the appropriate pair wise post hoc statistical test. Student's t test was used for two-group comparisons. A level of statistically significant difference was accepted at p Ͻ 0.05.
Results
Depletion of Foxp3 ϩ T regs in hapten-induced colitis
Consistent with previous observations (11), DNBS treatment of BALB/c mice resulted in a transient colitis characterized by weight loss, diarrhea, tissue edema, ulceration, and loss of tissue architecture. As assessed by clinical disease and histological damage scores, the severity of the DNBS-induced colitis peaked at 3 days posttreatment and resolved thereafter; by day 14 post-DNBS treatment, the mice appeared ostensibly normal although, upon histological examination, a small amount of inflammatory cell infiltrate was still apparent in the colon (Fig. 1, open bars) . A similar progression of clinical disease occurred in DNBS-treated C57BL/6 mice (data not shown), an observation consistent with other publications (12) . In addition, the inflammation elicited by the haptenizing agent oxazolone was maximal 3 days posttreatment (data not shown) with substantial improvement noted by 8 days posttreatment (Fig. 1, closed bars) .
The effect of inflammation on colonic Foxp3 ϩ T regs was assessed during overt inflammation and restitution by several complimentary techniques. RNA isolated from the colons of mice 8 days post-DNBS-induced colitis revealed complete abolition of detectable Foxp3 mRNA during restitution of inflammation as shown by RT-PCR ( Fig. 2A) . Significant reductions in the absolute number of Foxp3 ϩ cells and the proportion of CD4 ϩ Foxp3 ϩ cells in gated LPLs at 8 days post-DNBS treatment were also observed by immunohistochemistry (Fig. 2B ) and flow cytometry (Fig. 2C) . In addition, as determined by flow cytometry, the absolute number of CD4 ϩ Foxp3 ϩ T cells recovered from the colon 8 days post-DNBS treatment was significantly reduced (Fig. 2D) . Depletion of Foxp3 protein and mRNA was not unique to BALB/c mice, as colonic T reg depletion was also observed in gated LPLs from C57BL/6 mice as assessed by flow cytometry for mean percentage ( Fig. 2E; 1 .09 Ϯ 0.03% vs 0.49 Ϯ 0.03%) and absolute numbers of CD4 ϩ Foxp3 ϩ cells (Fig. 2F ). This phenomenon was not restricted to DNBS colitis, as reduced Foxp3 mRNA was detected in BALB/c mice 8 days posttreatment with oxazolone (Fig. 2G) .
The reduced number of Foxp3 ϩ cells was not due to dilution resulting from CD4 ϩ
Foxp3
Ϫ recruitment, as colonic (Fig. 2C ) and peripheral blood CD4 ϩ T cells were not increased until day 14 post-DNBS treatment (Fig. 3, A and B) . Thus, the absence of CD4 
Ϫ cells into the colon. Moreover (Fig. 3C) , suggesting an egress of these cells from the spleen and mucosal homing. Indeed, while mucosal homing ␣ 4 ␤ 7 ϩ CD4 ϩ Foxp3 ϩ cells are reduced in the blood 8 days post-DNBS treatment, T reg re-population of the colon occurred only when CD4 ϩ Foxp3 ϩ ␣ 4 ␤ 7 ϩ cells were found at normal (i.e., pretreatment) levels in the blood at 14 days post-DNBS treatment (compare Figs. 2B and 3B) .
In vitro induction of CD4
ϩ Foxp3 ϩ T regs is not directly affected by inflammatory cytokine exposure DNBS-induced colitis was associated with increased TNF-␣, IFN-␥, and IL-4 mRNA as detected by RT-PCR. To test the hypothesis that these proinflammatory mediators might underlay the loss of Foxp3 in the colon, purified CD4 ϩ T cells from the spleen were stimulated with anti-CD3 ϩ TGF-␤ ϩ and anti-CD28 (known to induce Foxp3) with or without IFN-␥, TNF-␣, or IL-4 (all 10 ng/ml). Pretreatment or cotreatment with IFN-␥, TNF-␣, or IL-4 failed to diminish the Foxp3 signal (data not shown). Similar changes in cytokine mRNA were noted in segments of terminal ileum (with or without Peyer's patches) from mice treated with DNBS, but this region of intestine showed neither signs of inflammation nor depletion of CD4 ϩ Foxp3 ϩ cells. These findings indicate that exposure to proinflammatory cytokines does not account for T reg depletion in the colon of colitic mice. 
The Journal of Immunology
DNBS-induced colitis results in dysfunctional SMAD signaling without affecting T cells
Having identified a tissue-specific depletion of Foxp3 ϩ T regs , we considered whether an inflammation-induced TGF-␤ signaling dysfunction was responsible for the depletion of colonic T regs , as this signaling cascade is critical for the induction and maintenance of T regs (7, 17) . Immunoblotting of protein extracts from colonic mucosal scrapings revealed an increase in the inhibitory SMAD7 protein at 8 days post-DNBS treatment, correlating with the depletion of colonic Foxp3 ϩ T regs (Fig. 4A, lower panel) . In accordance with our analysis of the mouse colon, increased SMAD7 expression in tissues from patients with inflammatory bowel disease (IBD) has been presented where increased IFN-␥ activity was postulated as being responsible for the SMAD7 signal (16) . Despite DNBS-induced increases in IFN-␥ mRNA (data not shown), IFN-␥-elicited signaling as gauged by STAT1 phosphorylation was not detected in the colonic mucosa (Fig. 4A, upper panel) . Inflammation-induced SMAD7 production was not restricted to the colonic mucosa, as expression was increased in Western blotting conducted on protein extracts from splenocytes and MLN cells 8 days post-DNBS treatment where Foxp3 ϩ cell numbers were unaltered (data not shown). However, this alteration to SMAD signaling did not effect CD4 ϩ T cells (and therefore not Foxp3 ϩ cells), as purified CD4 ϩ T cells from MLNs (data not shown) or flow cytometry of CD4 ϩ gated MLN and LPL cells revealed no increase in SMAD7 post-DNBS treatment (Fig. 4B) .
Inflammation-induced alterations to SMAD signaling were not restricted to increased SMAD7 expression. Western blotting and flow cytometry conducted on isolated MLN cells and splenocytes demonstrated that cells isolated from DNBS-treated mice, but not controls, exhibited increased basal SMAD2 phosphorylation and were refractive to TGF-␤ stimulation in vitro (data not shown).
Phosphorylation of SMAD2 in CD4
ϩ gated lymphocytes increased following TGF-␤ stimulation of LPLs from control mice from 7.91 Ϯ 0.05% to 69.8 Ϯ 1.8%. In contrast, 79.3 Ϯ 3.5% LPLs isolated from colon 8 days post-DNBS treatment had phosphorylated SMAD, and this was not significantly increased by TGF-␤ treatment (77.0 Ϯ 3.9%) (Fig. 5B) . SMAD2 phosphorylation in CD4 ϩ gated MLN lymphocytes increased after TGF-␤ stimulation from 4.00 Ϯ 0.25% to 81.5 Ϯ 2.8% and 62.7 Ϯ 10.9% to 83.9 Ϯ 1.9% in control and DNBS-treated mice, respectively. Thus, SMAD signaling dysfunction in CD4 ϩ T cells elicited by DNBS-induced colitis is restricted to saturation of the SMAD signaling cascade. Additionally, as altered SMAD signaling occurs in tissues without subsequent decreases in T regs , SMAD signaling dysfunction cannot be the primary event responsible for the depletion of colonic T regs .
Depletion of colonic Foxp3 ϩ T cells is Fas dependent
Given that Fas ligation induces apoptosis in human T regs (18) and the effect of Fas stimulation on mouse T regs had not been reported, we assessed the contribution of Fas/FasL interaction to the depletion of colonic T regs . Colonic FasL mRNA expression in DNBStreated mice followed a pattern of expression that was opposite to that of Foxp3, increasing 3 and 8 days post-DNBS treatment (Fig.  5A ). Fas mRNA expression was constitutive and unaltered by inflammation (Fig. 5A) . Immunohistochemistry for FasL confirmed significantly increased numbers of FasL ϩ lamina propria mononuclear cells and epithelial cells 3 days post-DNBS treatment ( ϩ Foxp3 ϩ cells was constitutive and remained unchanged 3 days post-DNBS treatment, a time when inflammation is ongoing and T regs are still present (data not shown). We assessed the susceptibility of T regs to Fas/FasL-induced apoptosis by stimulating naive BALB/c splenocytes with the Fas-activating mAb Jo-2 with or without anti-CD3 in vitro, monitoring for caspase 3 cleavage by flow cytometry. Cleaved caspase 3 was significantly increased in CD4 ϩ Foxp3 ϩ -but not CD4 ϩ Foxp3 Ϫ -gated T cells after incubation with Jo-2 with or without anti-CD3 (Fig. 6) , demonstrating that mouse Foxp3 ϩ T regs are sensitive to Fas-induced apoptosis. 
LOCAL INFLAMMATION REGULATES Foxp3 ϩ T CELLS
To determine whether colonic T reg depletion was due to increased Fas/FasL interactions, we evaluated this T cell population following DNBS-induced colitis in mice deficient in both Fas (lpr/ lpr) and FasL (gld/gld). Mice were given DNBS i.r. at 5 wk of age, a time when there was no evidence of autoimmunity or lymphoadenopathy (19) . Despite the deficiency in both Fas and FasL, DNBS treatment of these mice resulted in disease as assessed by clinical disease scores (Fig. 7A) . Additionally, colonic T reg depletion was not observed, with CD4 ϩ Foxp3 ϩ cells comprising 2.7 Ϯ 0.23% and 2.23 Ϯ 0.17% of gated LPLs 8 days post-EtOH and post-DNBS treatment, respectively ( Fig. 7 ; n ϭ 3 mice/group).
To decisively assess the contribution of Fas/FasL-induced apoptosis to the reduction of Foxp3 ϩ cells, Thy1.2 ϩ B6-Fas ϩ/ϩ or Thy1.2 ϩ B6-Fas Ϫ/Ϫ T regs were adoptively transferred into synergic Thy1.1 ϩ recipients 3 days before DNBS treatment (Fig. 8, A and  B) . Although the severity of DNBS-colitis was not reduced in Thy1. (Fig. 8D) 
Discussion
Although T and B cells are important components for maintaining an individual's overall health status, they also participate in the development of autoimmune disease and immunopathology. It has become apparent that Foxp3 ϩ T cells are critically involved in the suppression of immune responses, as both mice and humans lacking Foxp3 develop severe multiorgan pathology and a potentially fatal autoimmune syndrome (20 allows for activation of self-reactive effector T cells and the development of autoimmune disease (21) . Thus, Foxp3 ϩ T cells are considered beneficial and numerous studies have revealed their ability to reduce inflammation in the gut (10, 22) and joints (23) . However, although seminal observations have been made on the factors/conditions that control Foxp3 ϩ T reg development (17) and function in suppressing immune responses (7, 22, 24) , there is a lack of data on the fate of T regs during inflammation. In light of studies demonstrating that adoptive transfer of T regs reduces the severity of colitis in mice, our goal was to assess the fate of colonic T regs in mice with hapten-induced colitis.
Intrarectal administration of DNBS results in a self-limiting colitis with tissue damage peaking ϳ3 days posttreatment and resolving thereafter (11, 25) . BALB/c and C57BL/6 mice treated with DNBS (or oxazolone) show transient depletion of colonic ϩ T regs following epithelial restitution would remove the suppressive influence over local effector cells, allowing them to mount a response to any residual bacteria in the tissue (26) . It is also feasible that the absence of T regs could leave the host vulnerable to immunopathological events should there be a concomitant bacterial insult (27) . For instance, CD4 ϩ CD25 high blood cells and LPLs from Helicobacter pylori infected-patients have significantly increased Foxp3 expression (28) , limiting the development of gastritis while preventing bacterial clearance (27) . Similarly, infection with Leishmania major is accompanied by increased T regs (29) , with enhanced parasite clearance occurring after T reg depletion. In addition, this co-opting of regulatory cells by pathogens not only suppresses the adaptive immune system but also the components of innate immunity (30, 31) .
At least three possible explanations exist for the depletion of T reg from the colon of mice with colitis: 1) inflammatory cytokines affect TGF-␤ signaling required for Foxp3 ϩ T regs ; 2) reduced availability of systemic T regs ; and, 3) enhanced apoptosis of colonic T regs . We addressed each of these possibilities.
Following DNBS treatment, a rise in local and systemic levels of proinflammatory cytokines occurs, including those of IFN-␥ and others (11, 32) . However, and consistent with other reports, exposure to IFN-␥, TNF-␣, or IL-4 did not reduce the expression of Foxp3 in anti-CD3 (with or without anti-CD28) plus TGF-␤-treated CD4 ϩ cells in vitro. Given the ability of IFN-␥ to inhibit TGF-␤-elicited signal transduction (33) and the critical importance of TGF-␤ to the induction and survival of T regs (7, 9, 17) , we reasoned that a local inflammatory response may decrease peripheral T reg survival. Additionally, as colonic LPLs from IBD patients have increased expression of SMAD7 (34) , an inhibitor of TGF-␤-SMAD signaling, the contribution of SMAD7 to T reg depletion was assessed. DNBS colitis enhanced SMAD7 expression in the colon, MLN, and spleen but, critically, not in CD4 ϩ T cells. This finding demonstrates that inflammation-induced SMAD7 expression cannot account for the loss of T regs , because the number of Foxp3 ϩ cells in the MLN and spleen 8 days post-DNBS treatment were similar to that of controls. Furthermore, flow cytometry revealed increased basal SMAD2 phosphorylation in CD4
ϩ LPLs and MLNs of DNBS-treated mice. Both the increase in SMAD7 in non-CD4
ϩ T cells and phospho-SMAD2 in T cells are suggestive of increased bioactive TGF-␤ during the restitution process. As evidence of this, it has been shown that patients with IBD have paradoxically increased TGF-␤ expression (35) and increased SMAD7 expression (36) . Although increased SMAD7 expression occurs in humans, this increase is not restricted to T cells in mice (37) . Highlighting this, mice with disruption of TGF-␤ signaling in epithelial cells have an increased susceptibility to mucosal damage and delayed repair (38) . Together, these and our data suggest that although altered TGF-␤ signaling is a consequence of enteric inflammation, it is unlikely to play a substantial role in the depletion of colonic Foxp3 ϩ T regs . Natural turnover of T regs in conjunction with reduced recruitment from the circulation could contribute to a local loss of T regs . As reduced CD4
ϩ Foxp3 ϩ cells were not detected in the spleen and MLN in DNBS-treated mice, peripheral pools of T regs existed to replenish the colon. However, peripheral blood CD4 ϩ Foxp3 ϩ cells were significantly reduced before colonic T reg depletion, adding credence to a reduced recruitment hypothesis. Colonic T regs did not recover until CD4 ϩ Foxp3 ϩ ␣ 4 ␤ 7 ϩ T cells were detected at normal levels in the blood 14 days post-DNBS treatment. Peripheral blood lymphocyte depletion has been described in colitis, which may be a result of anemia due to bleeding and/or damage to the thymus by recirculating T cells (39) . These data support the contention that reduced T reg recruitment to the colon by the mucosal homing integrin ␣ 4 ␤ 7 could contribute to reduced colonic T reg numbers; however, they do not satisfactorily explain the T reg depletion at 8 days post-DNBS treatment.
Regulatory T cell homeostasis is mediated by FasL, as deficiency in FasL increases the number of Foxp3 ϩ T regs (40) . In addition, human peripheral blood T regs are sensitive to FasL-mediated killing (18) , although similar findings have not been reported for mice. T cell homeostasis following inflammation can occur through the ligation of Fas on the T cell surface with FasL expressed by activated T cells (41) , or other cells, including dendritic cells (42) , intraepithelial leukocytes (43) , and neurones (44) , which can also increase their FasL expression. DNBS-induced colitis results in significantly increased expression of FasL on lamina propria mononuclear cells, the colonic epithelium, and smooth muscle cells. However, and notably, FasL was not increased in the ileum, spleen, or MLNs of DNBS-treated mice, and these tissues had normal numbers of CD4 ϩ Foxp3 ϩ cells. The correlation between increased FasL expression and loss of Foxp3 ϩ T regs suggested that apoptosis could account for T reg depletion, a hypothesis supported by in vitro studies demonstrating that murine CD4 ϩ Foxp3 ϩ but not CD4
ϩ Foxp3 Ϫ cells are sensitive to Fas-mediated cell death. The higher basal rate of apoptosis and the increased susceptibility of murine CD4
ϩ Foxp3 ϩ cells to apoptotic stimuli is intriguing and is in stark contrast to CD4 ϩ Foxp3 Ϫ cells from the same animals. Although this would be expected to impinge on immunoregulation, the reason for this is unclear, but we speculate that it may be due to decreased anti-apoptotic gene expression in T regs as has been reported in human Foxp3 ϩ cells (45, 46) . A role for Fas/FasL in T reg depletion following DNBS-induced colitis was further confirmed in vivo through use of mice deficient for both Fas and FasL (lpr/lpr gld/gld). Complementing previous reports (40) , these mice possessed increased CD4 ϩ Foxp3 ϩ T regs compared with wild-type mice. In support of our hypothesis, we found no depletion of Foxp3 ϩ T regs in the colonic LPL population in Fas/FasL-deficient mice 8 days post-DNBS treatment. Although these data are highly suggestive of the possibility that Fas/FasL regulates the number of T regs in the inflamed gut, it is important to note that soluble FasL is a chemoattractant for polymorphonuclear cells (47, 48) , primary components of the inflammatory infiltrate in DNBS colitis and, hence, the disease in the Fas/FasL Ϫ/Ϫ mice would be qualitatively different from that in normal mice. Although the loss of Foxp3 expression and conversion into another T cell type was conceivable, the adoptive transfer experiments argue against this possibility. Although the majority of reports describe the generation of Th17 cells from naive T cells in the presence of TGF-␤ and IL-6 (49), the conversion of T regs in the presence of IL-6 has been recently described in vitro (50) . Despite increased IL-6 expression occurring during hapten induced colitis (51) This study demonstrates that colonic inflammation in mice elicits a profound but localized and temporary depletion of CD4 ϩ Foxp3 ϩ T regs . We demonstrate for the first time that the loss of this immunoregulatory population occurs by a Fas-dependent mechanism. Repopulation of the colon with CD4 ϩ Foxp3 ϩ T regs occurs after the FasL signal subsides, by mechanism(s) that may involve ␣ 4 ␤ 7 -based homing and recruitment to the gut. Clearly, this system is dynamic and, as with all immune responses, the key to intestinal health and homeostasis is balance. Temporary removal of T regs may allow robust immune responses to occur following localized insult and injury. However, prolonged depletion could leave the host vulnerable to unchecked aggressive immune responses.
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